PRGO Q3 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B-4.1% YoY

Gross Profit

$377M36.1% margin

Operating Income

$73M7.0% margin

Net Income

$8M0.7% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$52M

Free Cash Flow

$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.1B

Total Liabilities

$5.6B

Stockholders' Equity

$4.4B

Cash & Equivalents

$432M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.1B	-4.1%
Gross Profit	$377M	$404M	-6.8%
Operating Income	$73M	$80M	-9.7%
Net Income	$8M	-$21M	+135.7%

Revenue Segments

Consumer Self-Care Americas

$646M62%

Consumer Self-Care International

$398M38%

Geographic Segments

UNITED STATES

$635M60%

Europe

$384M37%

Other Geographical Areas

$24M2%

IRELAND

$9M1%